Phototoxic effect of hypericin alone and in combination with acetylcysteine on Staphylococcus aureus biofilms

Photodiagnosis and Photodynamic Therapy

Volumn 12, Issue 2, 2015, Pages 186-192

  Kashef, Nasim ^a   Karami, Shima ^a   Djavid, Gholamreza Esmaeeli ^b  

^a UNIVERSITY OF TEHRAN   (Iran)

^b AVICENNA RESEARCH INSTITUTE   (Iran)

Author keywords

Acetylcysteine; Hypericin; Photodynamic inactivation; Staphylococcus aureus

Indexed keywords

ACETYLCYSTEINE; HYPERICIN; POLYSACCHARIDE; BACTERIAL POLYSACCHARIDE; PERYLENE; PHOTOSENSITIZING AGENT;

ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BIOFILM; CELL COUNT; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; IN VITRO STUDY; LIGHT; NONHUMAN; PHOTOTOXICITY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE; ANALOGS AND DERIVATIVES; COMBINATION DRUG THERAPY; DRUG EFFECTS; METABOLISM; PHOTOCHEMOTHERAPY; PROCEDURES;

STAPHYLOCOCCUS AUREUS;

ACETYLCYSTEINE; BIOFILMS; DRUG THERAPY, COMBINATION; PERYLENE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POLYSACCHARIDES, BACTERIAL; STAPHYLOCOCCUS AUREUS;

EID: 84930654352     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2015.04.001     Document Type: Article

References (47)

1. Sauer K., Camper A.K., Ehrlich G.D., Costerton J.W., Davies D.G. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 2002, 184:1140-1154.
2. Resch A., Rosenstein R., Nerz C., Gotz F. Differential gene expression profiling of Staphylococcus aureus cultivated under biofilm and planktonic conditions. Appl Environ Microbiol 2005, 71:2663-2676.
3. Stewart P.S., Costerton J.W. Antibiotic resistance of bacteria in biofilms. Lancet 2001, 358:135-138.
4. Secor P.R., James G.A., Fleckman P., Olerud J.E., McInnerney K., Stewart P.S. Staphylococcus aureus biofilm and planktonic cultures differentially impact gene expression, mapk phosphorylation, and cytokine production in human keratinocytes. BMC Microbiol 2011, 11:143.
5. Mah T.F.C., O'Toole G.A. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001, 9:34-39.
6. Kolter R., Greenberg E.P. Microbial sciences: the superficial life of microbes. Nature 2006, 441:300-302.
7. Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol 2007, 5:48-56.
8. Kirker K.R., Secor P.R., James G.A., Fleckman P., Olerud J.E., Stewart P.S. Loss of viability and induction of apoptosis in human keratinocytes exposed to Staphylococcus aureus biofilms in vitro. Wound Repair Regen 2009, 17(5):690-699.
9. Schierle C.F., De la Garza M., Mustoe T.A., Galiano R.D. Staphylococcal biofilms impair wound healing by delaying re-epithelialization in a murine cutaneous wound model. Wound Repair Regen 2009, 17(3):354-359.
10. Fazli M., Bjarnsholt T., Kirketerp-Møller K., Jørgensen A., Andersen C.B., Givskov M., et al. Quantitative analysis of the cellular inflammatory response against biofilm bacteria in chronic wounds. Wound Repair Regen 2011, 19(3):387-391.
11. Wainwright M. Photodynamic antimicrobial chemotherapy (PACT). J Antimicrob Chemother 1998, 42:13-28.
12. Grinholc M., Szramka B., Olender K., Graczyk A. Bactericidal effect of photodynamic therapy against methicillin-resistant Staphylococcus aureus strain with the use of various porphyrin photosensitizers. Acta Biochim Pol 2007, 54:665-670.
13. Wainwright M., Phoenix D.A., Laycock S.L., Wareing D.R., Wright P.A. Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol Lett 1998, 160:177-181.
14. Paz-Cristobal M.P., Royo D., Rezusta A., Andrés-Ciriano E., Alejandre M.C., Meis J.F., et al. Photodynamic fungicidal efficacy of hypericin and dimethyl methylene blue against azole-resistant Candida albicans strains. Mycoses 2014, 57:35-42.
15. Nafee N., Youssef A., El-Gowelli H., Asem H., Kandil S. Antibiotic-free nanotherapeutics: hypericin nanoparticles thereof for improved in vitro and in vivo antimicrobial photodynamic therapy and wound healing. Int J Pharm 2013, 454:249-258.
16. Yow C.M., Tang H.M., Chu E.S., Huang Z. Hypericin-mediated photodynamic antimicrobial effect on clinically isolated pathogens. Photochem Photobiol 2012, 88:626-632.
17. Rezusta A., López-Chicón P., Paz-Cristobal M.P., Alemany-Ribes M., Royo-Díez D., Agut M., et al. In vitro fungicidal photodynamic effect of hypericin on Candida species. Photochem Photobiol 2012, 88:613-619.
18. Engelhardt V., Krammer B., Plaetzer K. Antibacterial photodynamic therapy using water-soluble formulations of hypericin or mTHPC is effective in inactivation of Staphylococcus aureus. Photochem Photobiol Sci 2010, 9:365-369.
19. Hager B., Strauss W.S., Falk H. Cationic hypericin derivatives as novel agents with photobactericidal activity: synthesis and photodynamic inactivation of Propionibacterium acnes. Photochem Photobiol 2009, 85:1201-1206.
20. Kashef N., Borghei Y.S., Djavid G.E. Photodynamic effect of hypericin on the microorganisms and primary human fibroblasts. Photodiagnosis Photodyn Ther 2013, 10:150-155.
21. de Melo Wde C., Lee A.N., Perussi J.R., Hamblin M.R. Electroporation enhances antimicrobial photodynamic therapy mediated by the hydrophobic photosensitizer, hypericin. Photodiagnosis Photodyn Ther 2013, 10:647-650.
22. Perez-Giraldo C., Rodriguez-Benito A., Moran F.J., Hurtado C., Blanco M.T., Gomez-Garcia A.C. Influence of N-acetylcysteine on the formation of biofilm by Staphylococcus epidermidis. J Antimicrob Chemother 1997, 39:643-646.
23. Marchese A., Bozzolasco MGualco L., Debbia E.A., Schito G.C., Schito A.M. Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms. Int J Antimicrob Agents 2003, 22(Suppl. 2):95-100.
24. Schwandt L.Q., Van Weissenbruch R., Stokroos I., Van der Mei H.C., Busscher H.J., Albers F.W. Prevention of biofilm formation by dairy products and N-acetylcysteine on voice prostheses in an artificial throat. Acta Otolaryngol 2004, 2004(124):726-731.
25. Olofsson A.C., Hermansson M., Elwing H. N-acetyl-l-cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces. Appl Environ Microbiol 2003, 69:4814-4822.
26. Clinical and Laboratory Standards Institute Performance standards for antimicrobial disk susceptibility tests; approved standard. CLSI document M02-A11 2012, Clinical and Laboratory Standards Institute, Wayne, PA. 11th ed.
27. Sharma M., Visai L., Bragheri F., Cristiani I., Gupta P.K., Speziale P. Toluidine blue-mediated photodynamic effects on staphylococcal biofilms. Antimicrob Agents Chemother 2008, 52:299-305.
28. Stewart P.S. New ways to stop biofilm infections. Lancet 2003, 361:97.
29. Demidova T.N., Hamblin M.R. Effect of cell-photosensitizer binding and cell density on microbial photoinactivation. Antimicrob Agents Chemother 2005, 49:2329-2335.
30. Usacheva M.N., Teichert M.C., Biel M.A. Comparison of the methylene blue and toluidine blue photobactericidal efficacy against gram-positive and gram-negative microorganisms. Lasers Surg Med 2001, 29:165-173.
31. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
32. Zanin I.C., Lobo M.M., Rodrigues L.K., Pimenta L.A., Höfling J.F., Goncalves R.B. Photosensitization of in vitro biofilms by toluidine blue O combined with light-emitting diode. Eur J Oral Sci 2006, 114:64-69.
33. Gad F., Zahra T., Hasan T., Hamblin M.R. Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria. Antimicrob Agents Chemother 2004, 48:2173-2178.
34. Marzullo L. An update of N-acetylcysteine treatment for acute acetaminophen toxicity in children. Curr Opin Pediatr 2005, 2005(17):239-245.
35. Oldemeyer J.B., Biddle W.P., Wurdeman R.L., Mooss A.N., Cichowski E., Hilleman D.E. Acetylcysteine in the prevention of contrast induced nephropathy after coronary angiography. Am Heart J 2003, 146:E23.
36. Yip L., Dart R.C., Hurlbut K.M. Intravenous administration of oral N-acetylcysteine. Crit Care Med 1998, 26:40-43.
37. Kao L.W., Kirk M.A., Furbee R.B., Mehta N.H., Skinner J.R., Brizendine E.J. What is the rate of adverse events after oral N-acetylcysteine administered by the intravenous route to patients with suspected acetaminophen poisoning. Ann Emerg Med 2003, 42:741-750.
38. Kauffman C.A. Quandary about treatment of aspergillomas persists. Lancet 1996, 347:1640.
39. Dodd S., Dean O., Copolov D.L., Malhi G.S., Berk M. N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther 2008, 8:1955-1962.
40. Berk M., Copolov D.L., Dean O., Lu K., Jeavons S., Schapkaitz I., et al. N-acetylcysteine for depressive symptoms in bipolar disorder - a double-blind randomized placebo-controlled trial. Biol Psychiatry 2008, 64:468-475.
41. Stey C., Steurer J., Bachmann S., Medici T.C., Tramer M.R. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. Eur Respir J 2000, 16:253-262.
42. Mansouri M.D., Hull R.A., Stager C.E., Cadle R.M., Darouiche R.O. In vitro activity and durability of a combination of an antibiofilm and an antibiotic against vascular catheter colonization. Antimicrob Agents Chemother 2013, 57(1):621-625.
43. Drago L., De Vecchi E., Mattina R., Romanò C.L. Activity of N-acetyl-l-cysteine against biofilm of Staphylococcus aureus and Pseudomonas aeruginosa on orthopedic prosthetic materials. Int J Artif Organs 2013, 36(1):39-46.
44. Quah S.Y., Wu S., Lui J.N., Sum C.P., Tan K.S. N-acetylcysteine inhibits growth and eradicates biofilm of Enterococcus faecalis. J Endod 2012, 38(1):81-85.
45. Aslam S., Darouiche R.O. Role of antibiofilm-antimicrobial agents in controlling device-related infections. Int J Artif Organs 2011, 34(9):752-758.
46. Leite B., Gomes F., Teixeira P., Souza C., Pizzolitto E., Oliveira R. Staphylococcus epidermidis biofilms control by N-acetylcysteine and rifampicin. Am J Ther 2013, 20(4):322-328.
47. El-Feky M.A., El-Rehewy M.S., Hassan M.A., Abolella H.A., Abd El-Baky R.M., Gad G.F. Effect of ciprofloxacin and N-acetylcysteine on bacterial adherence and biofilm formation on ureteral stent surfaces. Pol J Microbiol 2009, 58(3):261-267.